4 completed, 1 not yet recruiting, 1 terminated, 1 unknown. 7 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 7 | Completed 4, Not yet recruiting 1, Terminated 1, Unknown 1 |
Follow Central Retinal Vein Occlusion: new trials by email Literature Review of Central Retinal Vein Occlusion trials Research Report on Central Retinal Vein Occlusion
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Emerging Indications for Hyperbaric Oxygen Treatment Hyperbaric oxygen treatment (HBOT), 100% Oxygen - Post-COVID-19 Condition, Ulcerative Colitis | Phase 4 | Not yet recruiting | Jay C. Buckey Jr. | 100 | 2026-11-01 | 2026-09-09 |
| Evaluation of a Treat and Extend Regimen of Intravitreal Aflibercept for Macular Edema Secondary to CRVO Aflibercept (Eylea, BAY86-5321) - Central Retinal Vein Occlusion | Phase 4 | Completed | Bayer | 162 | 2016-06-10 | 2020-07-08 |
| Peripheral and Macular Retinal Vascular Perfusion and Leakage in DME and RVO Aflibercept - Retinal Vein Occlusion, Diabetic Macular Edema | Phase 4 | Completed | Justis Ehlers | 31 | 2015-08-18 | 2021-05-12 |
| Comparing Injection Frequency Between Aflibercept and Ranibizumab in Patients With CRVO With a Treat& Extend Regimen Aflibercept, Ranibizumab - Central Retinal Vein Occlusion | Phase 4 | Completed | Anders Kvanta | 40 | 2014-10-01 | 2020-12-04 |
| Ozurdex Versus Ranibizumab Versus Combination for Central Retinal Vein Occlusion Ozurdex, Ranibizumab, Combination Ozurdex with Ranibizumab PRN - Macular Edema, Central Retinal Vein Occlusion | Phase 4 | Unknown | Valley Retina Institute | 45 | 2013-05-01 | 2015-12-14 |
| Hemodilution Versus Ranibizumab in Early-onset Central Retinal Vein Occlusion ranibizumab, hemodilution - Central Retinal Vein Occlusion | Phase 4 | Completed | Centre Hospitalier Intercommunal Creteil | 45 | 2010-01-01 | 2014-08-13 |
| Treatment of Bevacizumab and Triamcinolone in Treatment or Macular Edema Secondary to CRVO bevacizumab and triamcinolone - Macular Edema, Central Retinal Vein Occlusion | Phase 4 | Terminated | Asociación para Evitar la Ceguera en México | 10 | 2007-06-01 | 2024-05-30 |
Retinal Vein Occlusion (7) · Macular Edema (3) · Calciphylaxis (1) · Colitis, Ulcerative (1) · Craniocerebral Trauma (1) · Crohn Disease (1) · Enterocolitis, Pseudomembranous (1) · Epidermolysis Bullosa (1) · Frostbite (1) · Graft vs Host Disease (1) · Hypospadias (1) · Invasive Fungal Infections (1) · Multiple Sclerosis (1) · Myositis, Inclusion Body (1) · Optic Neuropathy, Ischemic (1)
Cardiovascular Diseases (7) · Embolism and Thrombosis (7) · Eye Diseases (7) · Retinal Diseases (7) · Thrombosis (7) · Vascular Diseases (7) · Venous Thrombosis (7) · Macular Degeneration (3) · Retinal Degeneration (3) · Arterial Occlusive Diseases (1) · Autoimmune Diseases (1) · Autoimmune Diseases of the Nervous System (1) · Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Bone Diseases (1)
Ranibizumab (3) · aflibercept (3) · Bevacizumab (1) · Calcium Dobesilate (1) · Dexamethasone (1) · Hemodilution (1) · Oxygen (1) · Triamcinolone (1)
Anders Kvanta (1) · Asociación para Evitar la Ceguera en México (1) · Bayer (1) · Centre Hospitalier Intercommunal Creteil (1) · Jay C. Buckey Jr. (1) · Justis Ehlers (1) · Valley Retina Institute (1)
France (2) · United States (2) · Australia (1) · Canada (1) · Denmark (1) · Germany (1) · Italy (1) · Mexico (1) · Spain (1) · Sweden (1) · United Kingdom (1)
Carmen Gonzalez-Mijares, Physician (1) · Hugo Quiroz-Mercado, Retinologyst (1) · Jay Buckey (1) · Juan Manuel Jimenez Sierra, Retinologyst (1) · Justis P Ehlers, MD (1) · MA Martinez-Castellanos, Physician (1) · Octavio Burgos Vejar, Physician (1) · Omar Honerlager, preresident (1) · Raul Velez-Montoya, Physician (1) · Sofie Westman (1)
PMID 27409478, PMID 31757691, PMID 33556381
2009 (1), 2014 (1)